IASLC Academy | IASLC
The IASLC Academy is a prestigious program geared toward early-career physicians worldwide who aspire to pursue academic careers in thoracic oncology.
Related Articles
European Commission Approves Lazertinib Plus Amivantamab in First-Line EGFR-Mutated NSCLC
The European Commission has approved a type II variation extended indication for lazertinib plus amivantamab in frontline EGFR-mutated NSCLC.
Incretin mimetics in reducing breast cancer risk
Neil Iyengar, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the potential of incretin mimetics to reduce breast cancer risk, particularly in…
PM8002/BNT327 Combo Improves Efficacy and Safety in Metastatic TNBC
Data from a phase 1b/2 study show a 78.6% ORR in patients with metastatic triple-negative breast cancer treated with PM8002/BNT327 plus nab-paclitaxel.
Patients with heart disease may be at increased risk for advanced breast cancer
Cardiovascular disease (CVD) and cancer are the two leading causes of death in the U.S. According to researchers from The University of Texas MD Anderson…
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injecti
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection
Submit Late-Breaking Abstracts | Society of Gynecologic Oncology
The call for late-breaking abstracts for the Society of Gynecologic Oncology (SGO) 2025 Annual Meeting on Women’s Cancer is now open! The deadline for submissions…
FDA Grants Priority Review to Avutometinib Plus Defactinib for KRAS+ Recurrent Low-Grade Serous Ovarian Cancer
The FDA has granted priority review to the NDA for avutometinib plus defactinib in KRAS-mutant recurrent low-grade serous ovarian cancer.
Registration
Register for the AACR Annual Meeting 2025, taking place April 25-30 in Chicago, Illinois.
Hema Now: Episode 7: Decoding T Cells and Advancing Immunology
Discover the immunobiology of Myelodysplastic syndrome and Aplastic anaemia, the role of CD4+ T cells in myeloid malignancies, and more. Listen today
ClinicalTrials.gov
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
